Last updated · reviewed by the Essentras editorial team
Industry playbook
Healthcare PR: how medical and health brands get press (and what it costs)
Health brands get press with news a reporter can check: data, independent experts and disclosed conflicts. You can pitch health journalists yourself, hire an agency (5W says its healthcare programs start around $15,000 a month) or buy a paid placement with the label its listing states (median $1,931). Regulated claims go to a regulatory lawyer first.
Sources: the FDA, the FTC, the eCFR, HHS, the Association of Health Care Journalists, EurekAlert!, agency pages, and 324 health listings in the Essentras API
What you will do
- See how health journalists vet a story: evidence, conflicts of interest, independent experts and embargoes.
- Read the US rules that touch health claims (FDA, FTC) and patient stories (HIPAA), on the official pages.
- Compare pitching, agencies, EurekAlert!, wires and paid placements by published price.
- Check 29 health, medical and announcement listings with price, turnaround and label.
- Pick 1 of 3 baskets quoted today ($1,874.70, $5,040 or $53,095.50), with templates and a review checklist.
Start here in 1 click
The health catalog sorted by price, a news page for an announcement, and a free shortlist. None needs an account.
Health and medical outlets, cheapest first
Every health listing with its price, turnaround, link policy and label, before you pay.
- In the API
- 324 health and medicine
- In the US
- 62, median $660
- At $500 or less
- 78 listings
- Median price
- $1,931 (all markets)
AP News press release page
$317
- Turnaround
- 3 to 5 business days
- Label
- Published with a sponsored or partner label.
- Use it for
- Reviewed company news: funding, a clearance, a launch
AI Match: a shortlist for your news
Free. Describe your company or study in 1 sentence and get a ranked list of outlets that fit, with the price next to each.
Paid placements are paid: they are not earned coverage, and each runs with the label its listing states. Counts from the public API, 3 Nov 2026. Health content needs regulatory review before any paid page goes live.
How journalists vet
How do health journalists decide what to cover?
Health reporters write for readers who may make medical decisions from the story, so they check the evidence, the money and an outside opinion before they write. The Association of Health Care Journalists' Statement of Principles is the checklist your pitch will meet.
| What they check | What to have ready |
|---|---|
| Who pays and who gains: the financial interests of everyone quoted | Funding, stock, fees and advisory roles of every spokesperson and author, in writing |
| Independent voices: AHCJ asks members to avoid single-source stories | 2 or 3 experts with no tie to you who agreed to take calls |
| The stage of the evidence: Phase I trials mainly test safety, not efficacy; lab and animal results call for caution | The study type, size and stage, said plainly in the first paragraph |
| The size of the effect, in absolute and relative terms | Absolute numbers next to relative ones, and the number needed to treat where it applies |
| Harms, cost, insurance coverage and alternatives | Side effects, price, coverage status and other options |
| Sensational words: AHCJ lists cure, miracle, breakthrough, promising and dramatic | A release without them |
No gifts, no unsolicited samples
AHCJ asks members to refuse gifts and meals from drug and device companies and unsolicited product samples sent by mail. Offer data and access instead.
Quotes from releases are avoided
AHCJ asks members to avoid quotes from printed news releases and to label release material they use. Offer a real interview.
Bad news gets covered too
AHCJ asks for later failures and negative findings to get coverage comparable to the first positive report. Plan for that story.
Patients are not props
AHCJ asks reporters not to exploit illness for drama and to choose anecdotes that match the wider evidence. A patient story that only shows the best outcome invites the question you did not answer.
Embargoes and journals
How are medical research announcements timed?
Research news is usually timed to the moment the paper is published. Journals and research institutions share it with registered reporters in advance, under an embargo: a rule against publishing before a set date and time.
What an embargo is
EurekAlert!, the AAAS news service, defines an embargo as a prohibition on making information public before a set date and time, usually the paper's publication. Reporters who agree get the paper and contacts early.
Who sets it
EurekAlert! enforces embargoes set by content owners such as journal publishers and scientific meeting organizers, and makes each embargoed release public at its release time.
Who can post
EurekAlert! accepts releases only from press officers at organizations that conduct, publish or fund research. Paying the fee does not mean a release is accepted.
Weekly rhythms
Nature Portfolio journals send a joint press release every Monday about papers scheduled for online publication the following Monday (support page modified 15 Oct 2024).
Close-hold embargoes
AHCJ asks reporters to be wary of embargoes that bar them from consulting outside sources, and to tell readers when they accept such terms. Do not request them.
Before the paper is out
Read the target journal's own embargo and prior-publication policy before you talk to any reporter about unpublished work.
| Who posts | 1 release | 5 releases | 10 releases | Annual plan |
|---|---|---|---|---|
| Non-profit organizations | $198 | $891 | $1,683 | $1,803 for 65 releases; $2,722 unlimited |
| For-profit academic publishers | $448 | $2,016 | $3,808 | $3,642 for 65 releases; $5,496 unlimited |
| Other for-profit organizations | $1,575 | $7,088 | $13,388 | $9,975 for 35 releases |
| PR agencies and consultants | $448 or $1,575, by client type | Not listed | Not listed | Not eligible |
- EurekAlert! is run by the American Association for the Advancement of Science (AAAS). Fees pay for submission; each release is checked against its eligibility guidelines.
If the news is about a drug still in trials, FDA's rule on investigational drugs (21 CFR 312.7) bars representing, in a promotional context, that it is safe or effective for the use under study. The same rule says it does not restrict the full exchange of scientific information, including in scientific or lay media. Where a given release falls is a question for regulatory counsel.
FDA and FTC rules
Which US rules apply to health claims in press and paid content?
FDA has primary responsibility for claims in labeling and regulates prescription drug advertising; the FTC has primary responsibility for advertising claims for foods, supplements, over-the-counter drugs and other health products. This summarizes their own pages and is not legal advice: a regulatory lawyer reviews any regulated claim.
| Product or content | Agency | What the rule says | What it means for PR | Source |
|---|---|---|---|---|
| Prescription drug ads | FDA | Ads must present a true statement of side effects, contraindications and effectiveness. On 9 Sep 2025 FDA said it was sending thousands of letters about misleading ads and named undisclosed paid influencer promotion as a concern. | Run any paid article or influencer post about a prescription drug through the same regulatory review as an ad, with risk information and disclosed financial ties | 21 CFR 202.1; FDA press release, 9 Sep 2025 |
| Drugs still in trials | FDA | No promotional claim that an investigational drug is safe or effective; scientific exchange, including in lay media, is not restricted | Report results as results, with their limits | 21 CFR 312.7 |
| Supplements, foods, over-the-counter drugs, health equipment and apps (advertising) | FTC | Claims need competent and reliable scientific evidence, generally randomized, controlled human clinical trials; press releases and interviews count as advertising | Every claim in a release or an interview needs that evidence on file | FTC Health Products Compliance Guidance (December 2022) |
| Supplement labels | FDA | Structure/function claims need a disclaimer that FDA has not evaluated them; FDA must be notified within 30 days; disease claims are not allowed | Keep releases within the claims on the label | FDA, Structure/Function Claims (current as of 28 Mar 2024) |
| Health software and apps | FDA | Software that meets the device definition, such as an app that diagnoses heart rhythm problems, is regulated; minimal-risk functions fall under enforcement discretion | Describe only what the product is cleared or designed to do | FDA, Device Software Functions (current as of 27 May 2026) |
| Testimonials and endorsements | FTC | A testimonial is not proof; material connections must be disclosed; results better than people generally get need a clear disclosure of typical results ("results not typical" is not enough) | Patient and doctor quotes need disclosed payments and typical results | 16 CFR 255.5; FTC Health Products Compliance Guidance |
No medical advice, no treatment claims
This page makes no claim about any treatment and gives no medical or legal advice. When a release, a pitch or a paid article includes a regulated claim, a regulatory lawyer reviews it before it leaves your hands.
Patients and HIPAA
Patient stories and HIPAA: what needs written authorization?
HIPAA's Privacy Rule binds covered entities: health plans, health care clearinghouses and providers who transmit health information electronically in covered transactions (45 CFR 160.103). For a hospital, clinic or practice, a patient story usually means disclosing protected health information.
- Marketing needs a signed authorization. A covered entity must obtain an authorization to use or disclose patient information for marketing, except face-to-face communications and promotional gifts of nominal value; if a third party pays, the authorization must say so (45 CFR 164.508(a)(3)).
- A valid authorization names the information, who discloses it, to whom, the purpose and an expiry, is signed and dated, and tells the patient they can revoke it in writing. Treatment generally cannot be conditioned on signing it (45 CFR 164.508(b)(4) and (c)).
- Film crews and reporters need each patient's written authorization. HHS's FAQ says providers may not let media into treatment areas where patient information is accessible without it, and that asking the crew to blur faces or alter voices is not enough (HHS FAQ, last reviewed 9 Jan 2023, read 4 Nov 2026).
- A film crew or agency you hire to make PR material where patient information is accessible acts as your business associate: HHS says the provider signs a business associate agreement with it (45 CFR 164.504(e)), and publishing the material needs each patient's authorization.
- Replies to online reviews are disclosures too. HHS settled with or fined 4 practices whose replies to reviews disclosed patient information, for $10,000 to $50,000 each (HHS pages, read 16 Oct 2026).
- Not a covered entity? A wellness brand or an app outside HIPAA still answers to the FTC for its claims and testimonials. Ask counsel which rules bind you.
Routes and prices
Pitching, an agency, a wire or a paid placement: what does each cost?
Pitching and agencies aim at coverage a reporter decides. EurekAlert! and wires publish your release on their networks. A paid placement buys a page on a named outlet at a listed price, with the label its listing states.
| Route | What it costs, as published | Time to a live page | Who decides | What readers see |
|---|---|---|---|---|
| Pitch health reporters yourself | $0 | Days to months; research news follows the journal's embargo | The reporter and the editor | An article with independent experts and your conflicts named |
| Hire a healthcare PR agency | 5W: from around $15,000 a month. Everything-PR estimates $10,000 to $25,000 (health tech boutiques) up to $50,000 to $250,000 or more (pharma) | Months | Reporters decide; the agency pitches | The same as pitching |
| Post a research release on EurekAlert! | $198 (non-profit) to $1,575 (company) per release | At the embargo time | EurekAlert! accepts it; reporters decide on coverage | A release page, and coverage if reporters pick it up |
| Send a wire release | From $120 (PRWeb Basic) and $149 (EIN Presswire Basic) to $865 (ACCESS Newswire National) | The day you schedule | You | Your release, reposted by sites on the network |
| Buy a paid placement (Essentras) | $110 to $161,654; median $1,931 across 324 health listings; AP News press release page $317 | The window each listing states, such as 3 to 5 business days on Healthcare Business Today or 4 weeks or more on Healthline | You choose the outlet; it edits and publishes | An article or release page with the label its listing states |
What healthcare PR agencies publish about their fees
| Source | Figure, as published | What the figure is | Date |
|---|---|---|---|
| 5W Public Relations, healthcare agency guide | Healthcare programs start at around $15,000 a month, depending on scope | The agency's own starting price | Updated 29 Oct 2026 |
| Everything-PR, healthcare PR firms | Monthly retainers: health tech boutiques $10,000 to $25,000; full-service health tech $25,000 to $60,000; biotech and pre-IPO $20,000 to $60,000; pharma and global health systems $50,000 to $250,000 or more | Its own estimates, not rate cards; the site says its ownership overlaps with 5W | Updated 2 Nov 2026 |
- Where an agency gives no figure, this page gives none. Published retainers across industries are compared in the PR agency cost guide.
Outlets you can buy
Which health and medical outlets can you buy, and at what price?
The Essentras API returned 324 listings for health on 3 Nov 2026, 62 of them in the US. Every listing is a paid placement; prices, windows and labels below are as the listings state them.
| Scope | Listings | Median price | Middle half | At $500 or less | Labels |
|---|---|---|---|---|---|
| All markets | 324 | $1,931 | $517 to $6,693 | 78 | No label 145, sponsored or partner label 179, discreet 0 |
| US | 62 | $660 | $301 to $2,797 | 27 | No label 49, sponsored or partner label 13, discreet 0 |
- Count: GET /api/agent/v1/outlets?topic=health; the API matches the topic or the genre, so general news and lifestyle sites that list health as a genre are included.
US health, medical and science titles
| Outlet | Market | Price | Turnaround | Label, as the listing states it | Link | Note |
|---|---|---|---|---|---|---|
| Healthcare Business Today | US | $433 | 3 to 5 business days | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| The Health Grades | US | $500 | 3 to 5 business days | Published as a standard editorial article, with no sponsored label. | Dofollow | thehealthgrades.com, not Healthgrades |
| Pittsburghhealthcarereport.com | US | $650 | 1 to 3 business days | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Pharmatech News; Staff | US | $670 | 1 business day | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Science Times | US | $1,000 | 2 to 3 business days | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Medical Daily | Global | $4,167 | 1 week | Published as a standard editorial article, with no sponsored label. | Nofollow | Market listed as global |
| Muscle & Fitness (Includes Social Post); Includes Social Posts | US | $5,000 | 1 week | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Self | US | $11,667 | 2 to 3 weeks | Published as a standard editorial article, with no sponsored label. | Nofollow | |
| Healthcare Dive | US | $28,120 | 3 to 7 business days | Published with a sponsored or partner label. | Nofollow | |
| Healthcare Finance | US | $29,235 | 2 to 4 weeks | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| MobiHealthNews | US | $29,281 | 2 to 4 weeks | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Healthcare IT News | US | $29,281 | 2 to 4 weeks | Published as a standard editorial article, with no sponsored label. | Dofollow | |
| Live Science | US | $29,918 | 4 weeks or more | Published with a sponsored or partner label. | Nofollow | |
| Women's Health US | US | $91,572 | 4 weeks or more | Published with a sponsored or partner label. | Nofollow | |
| Every Day Health | US | $91,842 | 2 to 4 weeks | Published with a sponsored or partner label. | Dofollow | |
| Healthline | US | $91,842 | 4 weeks or more | Published with a sponsored or partner label. | Dofollow |
Health titles outside the US
| Outlet | Market | Price | Turnaround | Label, as the listing states it | Link |
|---|---|---|---|---|---|
| Medindia | IN | $595 | 1 to 3 business days | Published as a standard editorial article, with no sponsored label. | Nofollow |
| Health Magazine (UAE) | AE | $1,149 | 1 week | Published as a standard editorial article, with no sponsored label. | Dofollow |
| Wellness Daily | AU | $2,500 | 3 to 5 business days | Published as a standard editorial article, with no sponsored label. | Dofollow |
| Men's Health (Australia) | AU | $3,333 | 1 to 3 weeks | Published as a standard editorial article, with no sponsored label. | Dofollow |
| Women's Health (Australia) | AU | $3,333 | 1 to 3 weeks | Published as a standard editorial article, with no sponsored label. | Dofollow |
| Mejor con Salud | ES | $5,016 | 3 to 7 business days | Published as a standard editorial article, with no sponsored label. | Dofollow |
| Doctissimo.fr | FR | $9,031 | 1 to 2 weeks | Published with a sponsored or partner label. | Dofollow |
| Patient.info | GB | $44,781 | 4 weeks or more | Published with a sponsored or partner label. | Nofollow |
| MEN'S HEALTH Germany | DE | $77,817 | 2 to 4 weeks | Published with a sponsored or partner label. | Nofollow |
Press release pages for reviewed announcements
| Outlet | Market | Price | Turnaround | Label, as the listing states it | Link | Note |
|---|---|---|---|---|---|---|
| AP News; Press Release | Global | $317 | 3 to 5 business days | Published with a sponsored or partner label. | Nofollow | |
| Yahoo News/Finance; Press Release | Global | $667 | 3 to 5 business days | Published with a discreet disclosure. | Nofollow | |
| Business Insider / Yahoo / AP News; Press Release | US | $833 | 3 to 5 business days | Published with a discreet disclosure. | Nofollow | Business Insider, Yahoo and AP News in 1 listing |
| Reuters; Press Release | US | $3,000 | 1 to 2 weeks | Published with a sponsored or partner label. | Dofollow |
| Titles searched | What the search returned | The route instead |
|---|---|---|
| WebMD, Medscape, STAT, MedPage Today, Medical News Today, Verywell, Prevention, Harvard Health | 0 listings for each name | A pitch to the newsroom, or the publisher's own advertising team |
| Becker's, Modern Healthcare, Fierce Healthcare and Fierce Pharma, BioSpace, Endpoints (trade) | 0 listings for each name | A pitch to the newsroom, or the publisher's own advertising team |
Check the label, and review before you buy
145 of 324 health listings state no sponsored label. FDA named undisclosed paid influencer promotion as a concern in September 2025, and the FTC expects ads to be identifiable. For any drug, device or treatment content, regulatory review comes first, then a labeled page: a press release page such as AP News ($317), a listing that states a sponsored label (179 of 324), or a label you ask for in your brief. A paid page is never presented as independent coverage.
3 budget baskets
What does a healthcare placement budget buy?
3 baskets priced with the Essentras quote API on 3 Nov 2026, volume discount included. Each outlet links to its listing, where you see the label before you pay.
| Basket | Outlets (price each) | Subtotal | Volume discount | Total quoted | Cart |
|---|---|---|---|---|---|
| Health startup starterFirst news pages; each listing states 5 business days or less | Healthcare Business Today ($433), Pittsburghhealthcarereport.com ($650), Science Times ($1,000) | $2,083 | -$208.30 (10% volume discount) | $1,874.70 | Add these 3 to cart |
| Consumer health newsMedical Daily plus 2 smaller sites, for a consumer launch | Medical Daily ($4,167), Science Times ($1,000), Healthcare Business Today ($433) | $5,600 | -$560 (10% volume discount) | $5,040 | Add these 3 to cart |
| Health tech tradeFor health tech sold to hospitals and health systems | MobiHealthNews ($29,281), Healthcare IT News ($29,281), Healthcare Business Today ($433) | $58,995 | -$5,899.50 (10% volume discount) | $53,095.50 | Add these 3 to cart |
- Buy 3 or more placements for 10% off the basket, 5 or more for 15%. Refunded if not published, or if the turnaround is missed. Turnaround is counted in business days, paused while we are waiting on you, plus a 3 business day grace period.
- Every listing in these 3 baskets states no sponsored label. Use them for company news without health claims, or ask for a sponsored label in your brief; for drug, device or treatment content, use a labeled page.
Why the 3rd listing in the trade basket: MobiHealthNews and Healthcare IT News cost $58,562 together. Adding Healthcare Business Today ($433) makes 3 placements and 10% off the whole basket, so the total drops to $53,095.50, $5,466.50 less.
Announce in 8 steps
How to announce a study, a clearance or a product in 8 steps
An order that keeps the evidence, the rules and the reporters in step.
1. Name the kind of news
A published study, a regulatory decision, a product launch or company news. Each has its own rules and its own reporters.
2. Run regulatory and legal review
Every claim, quote and number goes to a regulatory lawyer; for drugs and devices, check each claim against the approved labeling or clearance.
3. Line up independent experts
Ask 2 or 3 experts with no tie to you whether reporters may call them, and write down your own conflicts of interest.
4. Use the journal's embargo
Release research news at the embargo time; post on EurekAlert! only if your organization is eligible.
5. Collect patient authorizations
If a patient appears, get a signed HIPAA authorization (covered entities) and the patient's written approval of the quotes and photos you supply.
6. Pitch with numbers and limits
Absolute and relative numbers, the stage of the evidence, side effects, cost and what is still unknown.
7. Publish paid pages after review
Paid placements and wires use the reviewed text. For drug, device or treatment content, use a labeled page or ask for the label in your brief; never present a paid page as independent coverage.
8. Follow up honestly
Answer questions the same day, correct errors and share later results, good or bad.
Templates
Copy-ready templates for healthcare PR
Placeholders are in [brackets]. Every claim, number and quote passes regulatory review first; no template is legal advice.
Embargoed study pitch to a health reporter
For a published study. Absolute numbers first, limits and conflicts in the body.
Subject: Embargoed until [date, time, time zone]: [finding in under 10 words] Hi [first name], Under embargo until [date, time, time zone]: [journal] publishes [study type, size] on [topic]. What it found: [absolute numbers, then relative]. Limits: [stage, size, population, unknowns]. Funding and conflicts: [who paid; authors' ties]. Independent experts who agreed to talk: [names, institutions]. [Name], [title], [organization] | [phone]
Patient story invitation (cover note)
Sent with your HIPAA authorization form, which counsel prepares. This note is not the form.
Hi [name], [Outlet] would like to tell a story about [topic]. Taking part is your choice, and your care does not depend on it. If you agree, we will ask you to sign [our authorization form], which says what we may share and with whom. You can revoke it in writing. You will see the quotes and photos we plan to share before we share them. A reporter may also ask you questions directly; answering is your choice. Questions: [name, phone]
Health tech news pitch to a trade reporter
For a launch, a contract or a clearance; regulatory status confirmed by counsel.
Subject: [Company] [news] for [buyer]: [1 number] Hi [first name], [What happened, 1 sentence]. Regulatory status: [as counsel confirmed]. Who uses it: [type of customer]; [1 result, with its source]. What it does not do: [limits]. [Customer contact] and [founder] are free [dates]. [Name], [company] | [press kit link]
Brief for a paid placement (health)
What to send with an Essentras order. You approve the draft before it goes live.
Outlet: [outlet name from the listing] Goal: [announcement | "as seen in" line | brand search results] Claims allowed (reviewed by [lawyer], [date]): [list] Required statements: [risk information, disclaimers] Patients: [none | authorization on file, [date]] Do not say: [cure, breakthrough, unreviewed claims] Label: [sponsored label requested | as the listing states it] Approval: [name, email]
Mistakes
Healthcare PR mistakes that cost trust
Overselling early results
Calling a Phase I or animal result a breakthrough: AHCJ tells reporters to avoid the word, and FDA bars promotional safety or efficacy claims for investigational drugs.
Hiding who paid
Reporters ask about funding and ties, and the FTC requires material connections to be disclosed.
Patient stories without authorization
A covered entity needs a signed authorization; HHS has settled with and fined practices even over patient details in replies to reviews.
Paid pages without review
A paid article is advertising; for drugs and devices it goes through the same regulatory review as any promotion.
Optional add-ons, and cheaper starts
Optional. You can do everything on this page without any of these.
Often added
Remove a Google review that breaks Google's rules
$499 for 1 review
For practices and clinics, without replying with patient details. Google decides every removal. The refund is ours to make. If Google does not remove the review, the full fee comes back.
Check a reviewA Knowledge Panel for the practice or founder
$650 or $1,200
Independent coverage gives Google sources to corroborate a physician, a founder or a company. Google decides whether a panel shows.
See the Knowledge Panel serviceTrack what AI assistants say
$49 a month
The AI Visibility Tracker asks patients' and buyers' questions to AI assistants every week and keeps every answer and its sources.
See the tracker
Not ready yet?
Press Monthly
$97 a month
1 press placement every month, matched to your niche and shown to you before we write. Cancel any time; plan months have no fixed turnaround.
See Press MonthlyA page on Medium
$97, 1 business day
A feature on Medium, a publishing platform, not a news outlet. The listing states: "Published as a standard editorial article, with no sponsored label."
Publish on MediumThe AI Visibility Baseline
$97
What AI assistants already say about your company, before you spend on coverage. The assistants decide what they answer.
See the baseline
FAQ
Frequently asked questions
What does a healthcare PR agency do?▾
It pitches health, medical and trade reporters, prepares spokespeople and data, plans news around journal embargoes and regulatory dates, and handles crises. 5W says its healthcare programs start around $15,000 a month; Everything-PR estimates $10,000 to $250,000 or more a month, by sector.
How much does healthcare PR cost?▾
Agencies: from around $15,000 a month (5W). A EurekAlert! research release: $198 to $1,575. A wire release: from $120 (PRWeb Basic). A paid placement: median $1,931 across 324 health listings on Essentras, or $317 for an AP News press release page.
How do medical and health tech companies get press coverage?▾
With news a reporter can check: data with absolute numbers, the stage of the evidence, independent experts who agreed to talk, disclosed conflicts and a clear regulatory status. Research news follows the journal's embargo; company news can go out as a release or a paid page after review.
Can a press release say a treatment works?▾
Not without the right basis. FDA requires balanced risk information in prescription drug ads and bars promotional claims that a drug still in trials is safe or effective. For other health products, the FTC generally expects randomized, controlled human trials. A regulatory lawyer reviews every claim.
Can we feature a patient in our PR?▾
If you are a HIPAA covered entity, only with the patient's signed authorization, and treatment cannot depend on it. HHS's FAQ says providers may not let media into areas with patient information without each patient's written authorization. Let the patient approve the quotes and photos you supply.
What is a medical journal embargo?▾
A rule against publishing research news before a set date and time, usually the paper's publication. Journals share papers with registered reporters in advance under it; EurekAlert! enforces embargoes set by journal publishers and meeting organizers. Check your journal's own policy before talking to reporters.
Is a paid health article the same as press coverage?▾
No. Coverage is a reporter's decision; a paid placement is a page you buy, with the label its listing states. 145 of 324 health listings state no sponsored label, so check it, and run any drug, device or treatment content through regulatory review first.
Does Essentras sell earned healthcare PR?▾
No. Essentras sells paid placements on 3,888 named outlets at listed prices, with the label each listing states, plus free tools to plan. For earned coverage, pitch reporters yourself or hire an agency.
Next steps
- 01
Name the news and its evidence
Study, decision, launch or company news, with its numbers and limits.
- 02
Get regulatory review
A regulatory lawyer reads every claim before a reporter or a paid page sees it.
- 03
Line up independent experts
And write down your own conflicts of interest.
- 04
Time it to the embargo
Research news goes out at the journal's time; company news on your date.
- 05
Price the pages you need
Start from a basket above, or the catalog sorted by price.
See every health listing
324 health and medical listings with price, turnaround, link policy and label. The consumer health basket above is $5,040 quoted today, volume discount included.
Browse health outlets Or get a free shortlist firstChecked on . Every Essentras price, turnaround, link policy, label, count and basket total here comes from the public catalog API, read on this date (baskets priced with the quote endpoint). Other figures carry their own source and date below.
Sources
- Association of Health Care Journalists, Statement of Principles, read 3 Nov 2026
- EurekAlert! (AAAS), Help and FAQ: embargoes and eligibility, read 3 Nov 2026
- EurekAlert! (AAAS), News Release Distribution Service rates (last updated 30 Apr 2026), read 3 Nov 2026
- Nature Support, AOP, press releases and embargoes (modified 15 Oct 2024), read 3 Nov 2026
- eCFR, 21 CFR 312.7, Promotion of investigational drugs, read 3 Nov 2026
- eCFR, 21 CFR 202.1, Prescription-drug advertisements, read 3 Nov 2026
- FDA, FDA Launches Crackdown on Deceptive Drug Advertising (9 Sep 2025), read 3 Nov 2026
- FDA, Structure/Function Claims (content current as of 28 Mar 2024), read 3 Nov 2026
- FDA, Device Software Functions Including Mobile Medical Applications (content current as of 27 May 2026), read 3 Nov 2026
- FTC, Health Products Compliance Guidance (December 2022), read 3 Nov 2026
- FTC, press release on the Health Products Compliance Guidance (20 Dec 2022), read 3 Nov 2026
- eCFR, 16 CFR 255.5, Disclosure of material connections (amended 26 Jul 2023), read 3 Nov 2026
- eCFR, 45 CFR 160.103 (covered entity) and 164.508 (authorizations), read 3 Nov 2026
- HHS, HIPAA FAQ on media and film crews in treatment areas (content last reviewed 9 Jan 2023), read 4 Nov 2026
- HHS OCR, enforcement over replies to online reviews: a $30,000 agreement (5 Jun 2023) and 3 dental cases (2019 to 2022), read 16 Oct 2026 for the doctors guide
- 5W Public Relations, How to Choose a Healthcare PR Agency (updated 29 Oct 2026), read 3 Nov 2026
- Everything-PR, Healthcare PR Firms: 20 Agencies for Pharma and Biotech (updated 2 Nov 2026), read 3 Nov 2026
- PRWeb, pricing, checked 14 Oct 2026
- EIN Presswire, pricing, checked 14 Oct 2026
- ACCESS Newswire, submit a press release (prices), checked 16 Oct 2026
- Essentras public catalog API: health listings (topic=health), read 3 Nov 2026
- Essentras public catalog API: baskets priced with POST /api/agent/v1/quote, 3 Nov 2026
Essentras sells paid placements on named outlets and does not sell earned PR. This page gives no medical, legal or regulatory advice and makes no claim about any treatment; a regulatory lawyer reviews regulated claims. Agency and service fees are their own published figures, as dated. Paid placements are not earned coverage.
More on healthcare PR, placements and costs
Adds us as a preferred source, so our guides surface for you in Search and AI answers. One click, and you can undo it any time.
Free tool · Authority Audit
Where does your authority actually stand?
Before you fix one piece, see the whole picture. A free Authority Audit scores your presence across Google, AI, Wikipedia, reviews, and press, and shows you exactly where to start.